Lilly’s oral SERD gets FDA nod in advanced breast cancer

The clearance of Inluriyo is another development among a group of oral medicines aiming to supplant a widely used, injectable ...
Zacks Investment Research on MSN

LLY Gets EU Approval for Alzheimer's Drug & FDA Nod to Cancer Therapy

Eli Lilly and Company LLY announced that the European Commission (EC) has granted marketing authorization to Kisunla ...
MedPage Today on MSN

Oral Breast Cancer Drug Wins Broader FDA Nod for ESR1-Mutated Disease

Imlunestrant joins elacestrant (Orserdu) as the only FDA-approved oral therapies for ESR1 -mutant breast cancer. In contrast ...
Medscape

FDA gives nod to antiobesity effects of rimonabant but balks at smoking-cessation indication

Paris, France - The US Food and Drug Administration (FDA) has told Sanofi-Aventis that its cannaboid-1 (CB1) receptor blocker rimonabant is "approvable" as a weight-loss drug but not as a ...

Ozempic gets India nod: Drug regulator approves Novo Nordisk's blockbuster diabetes drug

Ozempic, marketed by Novo Nordisk in India, is primarily indicated for the treatment of type 2 diabetes. While it can lead to ...
Medical Dialogues

Eli Lilly Inluriyo gets USFDA nod for adults with advanced breast cancer

Indianapolis: Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved Inluriyo ...